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Abstract: RNA editing is a post-transcriptional modification, which can provide tissue-specific 
functions not encoded in DNA. Adenosine-to-inosine is the predominant editing event and, along 
with cytosine-to-uracil changes, constitutes canonical editing. The rest is non-canonical editing. In 
this study, we have analysed non-canonical editing of microRNAs in the human brain. We have 
performed massively parallel small RNA sequencing of frontal cortex (FC) and corpus callosum 
(CC) pairs from nine normal individuals (post-mortem). We found 113 and 90 unique non-canonical 
editing events in FC and CC samples, respectively. More than 70% of events were in the miRNA 
seed sequence—implicating an altered set of target mRNAs and possibly resulting in a functional 
consequence. Up to 15% of these events were recurring and found in at least three samples, also 
supporting the biological relevance of such variations. Two specific sequence variations, C-to-A and 
G-to-U, accounted for over 80% of non-canonical miRNA editing events—and revealed preferred 
sequence motifs. Our study is one of the first reporting non-canonical editing in miRNAs in the 
human brain. Our results implicate miRNA non-canonical editing as one of the contributing factors 
towards transcriptomic diversity in the human brain. 
Keywords: microRNA; RNA editing; human brain 
 
1. Introduction 
Biological systems thrive on diversity. At the molecular level, diversity is often contributed by 
variations occurring at different steps of information processing, namely DNA to RNA and RNA to 
protein. RNA sequences can differ from their DNA templates owing to transcriptional errors and 
RNA editing [1,2]. Proofreading and repair mechanisms of transcription keep a check on 
transcriptional errors [3,4], making RNA editing one of the major contributors to RNA sequence 
diversity. The importance of RNA editing in diversity is even higher in tissues or organs where cells 
are not actively dividing—such as post-mitotic neuronal cells [5–7]. The predominant RNA editing 
event, mediated by ADAR (Adenosine Deaminase acting on RNA) results in adenosine-to-inosine 
change (A-to-I) in RNA [8–13]. Along with A-to-I, enzyme-mediated editing also includes cytosine-
to-uracil change (C-to-U) mediated by APOBEC (Apolipoprotein B mRNA-editing enzyme, catalytic 
polypeptide-like) [14,15]. A-to-I and C-to-U are categorized as canonical RNA editing. Initially, 
editing was identified in mRNAs. However, recent reports find the majority of the editing events 
within the non-coding regions of the genome [9,16–18]. Within non-coding RNAs, a large proportion 
of editing is found in Alu elements [19,20]. Elevated Alu editing is reported in multiple cancers 
leading to an increase in transcriptomic diversity [21]. Recent advances in next-generation sequencing 
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technologies have enabled researchers to investigate non-canonical editing events (other than A-to-I 
and C-to-U). The mechanisms behind these events are unknown and broadly classified as RNA–DNA 
differences (RDD). A recent study identified 10,000 exonic sites differing between RNA and DNA in 
B-cells, which translated into variant protein sequences implicating their functional relevance [22]. A 
few groups suggested these RDDs could be errors due to mapping, sequencing and genetic variations 
[23–25] However, the authors of the original study reproduced RDDs using orthogonal methods for 
both experiment and analysis [26]. Another independent study also found RDDs in human cytokine 
receptor, IL12RB1 [27]. IL12RB1 is important for human resistance against pathogens [28], and 
variation in IL12RB1 has been associated with multiple disease susceptibility [29]. It will be 
interesting to see whether RDDs in IL12RB1 can modify intra-individual and inter-tissue differences 
towards disease susceptibility. Further, a study also identified RDDs in proto-oncogenes and tumour 
suppressors [30]. Apart from these, several other studies have identified RDDs in different tissues 
[31–33]. These evidences show that, although the mechanism and extent of non-canonical editing is 
unknown, these are indeed true events with likely functional consequences and need further 
research.  
MiRNAs usually binds to the 3′-untranslated region (3′-UTR) of mRNAs leading to 
downregulation of gene expression [34]. The target recognition is facilitated by a protein complex 
called RISC which loads the mature miRNA and lodges it onto the 3′-UTR of the target mRNA to 
direct post-transcriptional repression [35,36]. In animals/metazoans, extensive complementarity 
between miRNA and its target leads to translational suppression and mRNA destabilization and 
degradation [37–39]. In particular, bases 2–8 from the 5′-end of the mature miRNA constitute the seed 
sequence and are critical for target recognition [40]. A-to-I editing within microRNAs has been well 
studied and can affect its processing [41,42] and result in redirection of targets [43]. MiRNA editing 
is implicated in tissue-specific regulation in both health and disease [41–50]. Reports of non-canonical 
editing in microRNAs are scarce [51–53] and the validity as well as functionality of these events needs 
further study. In this study, we have used massively parallel next-generation sequencing and 
analysed non-canonical editing in mature microRNAs in two different regions of normal human 
brain—namely, the frontal cortex and corpus callosum. 
2. Results and Discussion 
We have performed small RNA sequencing in paired samples of frontal cortex (FC) and corpus 
callosum (CC) from nine individuals (post-mortem samples) to identify editing events in the mature 
microRNA population (Supplementary Table S1). 
We overlapped the identified miRNA variant sites with dbSNP version151 (All SNPs) followed 
by exome data to filter out variations at the DNA level. However, it is worthwhile to note here that 
these variations (genome encoded) can still be in the resulting transcript (miRNA) and bring out 
possible functional consequences [54,55]. Further, all A-to-C modifications were excluded from the 
analysis due to specific biases of Illumina sequencers [56,57]. 
After filtering out these variations at the DNA level, the total number of canonical edits 
identified in FC were 255 (A-to-I = 211 and C-to-U = 44) and in CC were 177 (A-to-I = 136 and C-to-U 
= 41). In case of non-canonical miRNA editing, 175 and 158 events were detected in FC and CC, 
respectively (Supplementary Figure S1 and Supplementary Table S2). This observation was in 
agreement with previous literature reporting a higher proportion of canonical editing, especially A-
to-I, within mature miRNAs [51,52]. Interestingly, we observed inter-individual and intra-individual 
differences in terms of relative proportions of canonical and non-canonical editing events in mature 
miRNAs (Figure 1, Supplementary Figure S1). For example, we detected non-canonical editing events 
viz., miR-454_U-to-G, miR-30e_U-to-C etc., which were enriched in either FC or CC only—but not in 
both—indicating intra-individual tissue-specific non-canonical events (Table 1). 
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Table 1. Target prediction analysis of non-canonical miRNA editing events present in at least three 
FC and CC samples. 
MiRNA 
Strand/P
osition 
Seed 
Editing 
Types 
Presence in 
Samples (FC/CC) 
a Target Prediction 
(Before/After Editing) 
Overlap 
(%) 
hsa-miR-
100 
5p/3 Yes C-to-A 3/3 30/16 0 (0) 
hsa-miR-
127 
3p/4 Yes G-to-U 3/3 128/60 0 (0) 
hsa-miR-
146b 
5p/4 Yes G-to-U 3/2 502/111 9 (1.79) 
hsa-miR-
181c 
5p/3 Yes C-to-A 3/3 207/72 1 (0.48) 
hsa-miR-
181d 
5p/3 Yes C-to-A 3/2 580/269 21 (3.62) 
hsa-miR-
204 
5p/3 Yes C-to-A 3/3 498/90 6 (1.20) 
hsa-miR-
221 
3p/4 Yes U-to-G 3/0 378/103 5 (1.32) 
hsa-miR-
23a 
3p/3 Yes C-to-A 3/3 258/73 2 (0.78) 
hsa-miR-
23b 
3p/3 Yes C-to-A 3/3 372/106 5 (1.34) 
hsa-miR-
26b 
5p/3 Yes C-to-A 3/3 93/41 0 (0) 
hsa-miR-
301a 
3p/4 Yes U-to-G 2/3 184/508 7 (3.80) 
hsa-miR-
421 
Mature/3 Yes C-to-A 3/3 248/122 5 (2.02) 
hsa-miR-
433 
3p/3 Yes C-to-A 3/3 403/166 10 (2.48) 
hsa-miR-
99a 
5p/3 Yes C-to-A 3/3 35/23 0 (0) 
hsa-miR-
99b 
5p/3 Yes C-to-A 3/2 49/22 0 (0) 
hsa-miR-
454 
3p/4 Yes U-to-G 0/3 232/622 21 (9.05) 
hsa-let-
7a-1 
5p/9 No U-to-G 3/0 NA NA 
hsa-miR-
30a 
5p/19 No G-to-C 5/2 NA NA 
hsa-miR-
30a 
5p/19 No G-to-U 2/4 NA NA 
hsa-miR-
30d 
5p/19 No G-to-C 3/2 NA NA 
hsa-miR-
30e 
5p/19 No G-to-C 7/5 NA NA 
hsa-miR-
30e 
5p/17 No U-to-C 6/2 NA NA 
hsa-miR-
30e 
5p/18 No G-to-A 4/1 NA NA 
a Percentage overlap was calculated by overlapped targets/targets before editing. NA—Not applicable 
because they were not seed editing events. 
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Figure 1. Distribution of non-canonical editing within mature miRNAs in FC and CC. The figure 
shows 113 and 90 non-redundant non-canonical miRNA editing events and their overlap across nine 
(A) FC and (B) CC, respectively. Each row represents a single miRNA editing event. The events are 
alphabetically arranged according to miRNA name. For details, refer to Supplementary Table S2. Seed 
editing events are represented in pink and the non-seed in green. We did not detect any non-canonical 
miRNA editing events in CC5. 
Out of total non-canonical events, 113 and 90 events were unique in FC and CC, respectively 
(Figure 1A,B). More than 15% of these events recurred in at least three samples in both FC and CC 
(Figure 1A,B and Supplementary Table S2). While variation at any position within a microRNA can 
have an impact [41,46], a seed sequence variation can lead to target redirection [36]. Thus, a variation 
in the seed sequence can have a larger functional impact. Interestingly, 71.68% (81 out of 113) and 
74.44% (67 out of 90) of the non-canonical editing events were within the seed sequence in FC and 
CC, respectively (Figure 1A,B). The overlap between the predicted mRNA targets of the unedited 
and edited miRNAs was less than 10% (Table 1 and Supplementary Table S3), confirming the possible 
target redirection. The pathways enriched for the unedited and edited miRNAs targets were 
different. For example, gene ontology and pathway enrichment analysis for the unedited miR-433 
revealed genes involved in neuron development and differentiation, and pathways relating to 
chemical synapses and neuronal systems (Supplementary Table S4). Additionally, the edited version 
of this miRNA resulted in gene sets related to cell motility and locomotion (Supplementary Table S4). 
It is noteworthy that miR-433 showed considerable levels of editing (up to 36.6%) and was identified 
in six samples (FC and CC combined) which indicates an important biological role of the edited 
miRNA. It will be interesting to pursue if the unedited and the edited version both remains relevant 
in separate distinct stages of neurogenesis (e.g., axonal growth vis-à-vis pruning). 
Within non-canonical editing events found in our study, C-to-A and G-to-U events accounted 
for over 80% (Figure 2). C-to-A events were most abundant (44.24% (50/113) in FC and 54.44% (49/90) 
in CC), followed by G-to-U events (39.82% (45/113) in FC and 34.44% (31/90) in CC) (Figure 2A,B). 
Additionally, over 70% of the C-to-A and G-to-U events were within the seed sequence (Figure 2). 
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Figure 2. Distribution of different non-canonical editing within mature miRNAs. The different colours 
represent the types of non-canonical editing and their distribution within mature miRNA detected in 
(A) FC and (B) CC. The pink and the green bar over the panels correspond to seed and non-seed 
editing events from Figure 1. The events are alphabetically arranged according to miRNA name. For 
details, refer to Supplementary Table S2. A-to-U modification was not detected in the study. C-to-G 
and U-to-A modifications were not detected specifically in CC. 
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We have analysed whether sequence contexts in the miRNAs accounted for the two abundant 
events mentioned above. For both types, we analysed upstream and downstream sequence context 
with the edited base in the middle. For C-to-A-edited miRNAs, there was a preference for adenosine 
(p = 0.02) downstream of the edited cytosine and avoidance for guanosine on both sides (p = 0.02 and 
p = 0.009). We also found a lack of uracil (p = 0.04) downstream of the edited cytosine (Figure 3 and 
Supplementary Table S5). Additionally, “UCA” (13/58), “ACC” (13/58) and “CCA” (7/58) accounted 
for more than 55% of the triplets present in miRNAs harbouring C-to-A editing. Analysis of 1871 pre-
miRNAs revealed that the fractions of abovementioned triplets in pre-miRNAs were 0.017, 0.012 and 
0.018, respectively (Supplementary Figure S2 and Supplementary Table S5). For the G-to-U-edited 
miRNAs, a preference for adenosine both upstream (p = 0.002) and downstream of the edited 
guanosine was observed (Figure 3A and Supplementary Table S5). “AGG” and “AGA” were the top 
two enriched triplets (0.19 and 0.13, respectively) observed for miRNAs harbouring G-to-U editing. 
The corresponding frequencies of these triplets in in pre-miRNAs were 0.023 and 0.018, respectively 
(Supplementary Figure S3 and Supplementary Table S5). 
 
Figure 3. Analysis of sequence context for the non-canonical editing events. The figure shows the 
edited base in the middle (position 0) and the probability of the bases one base upstream (position −1) 
and downstream (position +1). (A) For C-to-A edited miRNAs, adenosine was a preferred base 
downstream (p = 0.02) and guanosine was avoided on either side of the edited cytosine (p = 0.02 and 
p = 0.009). Uracil was also not preferred downstream to the edited cytosine (p = 0.04). (B) For G-to-U-
edited miRNAs, adenosine was the preferred base both upstream (p = 0.002) and downstream of the 
edited guanosine. 
For the two most abundant editing types discussed above, the observed enrichment of motifs in 
editing events is not due to a preferred DNA sequence context common to miRNAs (Supplementary 
Figures S2 and S3; Supplementary Table S5). It is therefore likely that such enrichments indicate 
distinct, yet unknown, molecular mechanisms that recognize and utilize these motifs for post-
transcriptional modifications. The non-canonical events we reported can be considered as isomiRs 
under the category of nucleotide substitution events, which encompass a huge range of changes 
including A-to-I modifications [58–60]. Further studies and validation of non-canonical editing by 
orthogonal methods (Sanger sequencing) will be necessary to shed more light on such possible 
mechanisms. 
Interestingly, a recent genome-wide study detected non-canonical miRNA editing events and 
found that most of the U-to-G changes were detected in the superior frontal gyrus of brain samples 
[53]. We have also detected ten unique U-to-G editing events in our FC and CC samples. Additionally, 
the above study identified G-to-U seed editing events within let-7 members (also found in our study, 
Table 1) leading to specific enriched pathways. Enrichment of specific non-canonical editing in 
specific regions of the brain can have important biological consequences and needs further study. 
Single-cell sequencing of different brain cells will provide a better understanding of the functional 
role of non-canonical editing. We have shown that non-canonical editing in miRNA, especially in the 
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seed sequence, is a likely contributor to transcript diversity with potential functional consequences 
in the human brain. 
3. Materials and Methods 
3.1. Samples 
Portions of frontal cortex and corpus callosum were obtained from the NIMHANS Brain Bank, 
Bengaluru, India. These were collected post-mortem from road accident victims. The samples were 
ethically cleared for research purposes through the brain bank. Additionally, the institutional review 
board has provided ethical approval for the study. The study also adhered to the Declaration of 
Helsinki for the use of human samples. The details of the samples used in the study are provided in 
Supplementary Table S1. 
3.2. RNA Isolation, Library Preparation and Sequencing 
Briefly, total RNA was isolated from frontal cortex and corpus callosum using a miRvana 
miRNA isolation kit (Ambion, Austin, TX, USA) as per the manufacturer’s instructions. Libraries 
were prepared using Illumina’s TruSeq Small RNA Sample Prep Kit following the manufacture’s 
protocol. Two samples were loaded in one lane and 50-base single-end sequencing was done on an  
Illumina HiSeq 2000 platform. The small RNA sequencing data can be accessed in the sequence read 
archive (SRA ID: SRP063390). 
3.3. Data Analysis 
Data analysis was done using the published pipeline [61] with the default parameters. Briefly, 
low-quality reads and adapters were removed. Filtered reads were aligned to the genome using 
Bowtie 0.12.7, allowing unique best alignment and one mismatch. Next, reads were mapped to pre-
miRNA sequences. Binomial statistics were used to remove sequencing errors. Finally, Bonferroni 
correction was used to identify statistically significant variations. dbSNP version 151 (All SNPs) and 
exome sequencing data were used to filter out variations at the DNA level. The raw output of the 
miRNA editing pipeline is provided in Supplementary Table S6. 
3.4. Target Prediction and Functional Enrichment Analysis 
Target prediction for unedited and edited miRNAs was done using isoTar version 1.2 [62]. We 
selected the mRNA targets predicted by four out of five independent miRNA target prediction tools; 
viz. PITA, RNAhybrid, TargetScan, miRanda and miRmap. Following that, we did gene ontology 
and REACTOME pathway enrichment analysis using gene set enrichment analysis [63,64]. 
3.5. Sequence Context for the Edited miRNAs 
Unique non-canonical miRNA editing events combining FC and CC were used for analysis. This 
led to 58 C-to-A and 48 G-to-U events. One base upstream and one downstream of the edited base 
were fetched using an in-house script for the abovementioned edited miRNAs. Sequence preference 
around the edited base was visualized using WebLogo 3 [65]. To look for tri-nucleotide (triplet) 
sequence composition within pre-miRNAs, human pre-miRNAs were downloaded from miRBase 
version 20 and a three-base sliding window was used to analyse enriched tri-nucleotides using in-
house scripts. The entire statistical test relating to calculation of sequence context around the edited 
nucleotide has been done using a two-tailed test for proportion. 
The methods followed in this paper can be seen in more detail in our previous publication [47]. 
Supplementary Materials: The following are available online at www.mdpi.com/2311-553X/6/2/21/s1, Figure 
S1: Distribution of canonical and non-canonical miRNA editing events,, Figure S2: Enriched triplets for C-to-A 
edited miRNAs, Figure S3: Enriched triplets for G-to-U edited miRNAs, Table S1: Sample detail, Table S2: 
Mature miRNA editing with read counts FC CC, Table S3: isoTar miRNA target prediction, Table S4: miR-433 
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Gene ontology pathway, Table S5: Sequence context non-canonical editing FC CC, Table S6: Raw output of 
pipeline. 
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